Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA/ISOPP 2019 | Choosing cancer clinical trial endpoints

Bruce Burnett • 10 Oct 2019
BOPA/ISOPP 2019

Bruce Burnett, Swansea University, Swansea, UK, highlights the important considerations when choosing cancer clinical trial endpoints. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.

More from Bruce Burnett

2:37
Limitations with AI programs for prescription screening
Bruce Burnett • 12 Oct 2018
The content of VJOncology is intended for healthcare professionals